The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration-Reference-Cited by-同舟云学术

The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration

Published:2018-08-13 Issue:12 Volume:29 Page:2659-2665
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Tsuchie H.^ORCID,Miyakoshi N.,Iba K.,Kasukawa Y.,Nozaka K.,Dohke T.,Kosukegawa I.,Aizawa T.,Maekawa S.,Abe H.,Takeshima M.,Tomite T.,Segawa T.,Ouchi K.,Kinoshita H.,Suzuki M.,Yamashita T.,Shimada Y.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/article/10.1007/s00198-018-4658-7/fulltext.html

Reference24 articles.

1. Bamias A, Terpos E, Dimopoulos MA (2010) Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment. Onkologie 33:288–299

2. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1294–1301

3. Sasaki S, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y (2012) Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series. J Bone Miner Metab 30:561–567

4. McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM (2013) Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med 126:13–20

5. Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Cheung AM, Consman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 1:1–24

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and clinical course of femoral localized periosteal thickening and atypical femoral fracture over a 10-year period in patients with autoimmune inflammatory rheumatic disease;JBMR Plus;2024-07-10

2. Comparison of the Effectiveness of Teriparatide and Zoledronic Acid in Osteoporosis Treatment: A Meta-Analysis;International Journal of Pharmacology;2024-05-01

3. Effectiveness of teriparatide in in improving healing rates and bone-turnover markers of osteoporotic hip fracture: a meta-analysis;Journal of the Pakistan Medical Association;2024-02-01

4. Short-term Treatment Comparison of Teriparatide and Percutaneous Vertebroplasty in Patients with Acute Osteoporotic Vertebral Compression Fractures;Journal of the Korean Fracture Society;2024

5. Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture;Medical Principles and Practice;2023-12-15